Drugs / Salmeterol/fluticasone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03060044 | Jul → Nov 2016 | asthma | Orion Corporation, Orion Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Salmeterol/fluticasone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03060044 ↗ |
| Route | Inhaled | “Seretide Diskus 50/500 µg/Inhalation” NCT03060044 ↗ |